Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary

Piotr Skrzypczyk1, Anna Ofiara1, Michał Szyszka2

  • 1Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Insights

Serum sclerostin levels did not differ between pediatric hypertension patients and controls, but were associated with blood pressure and height in children. This suggests a link between sclerostin and blood pressure regulation in pediatric hypertension.

Area of Science:

  • Cardiovascular Research
  • Pediatric Endocrinology
  • Biochemistry

Background:

  • The Wnt/beta-catenin pathway and its inhibitor, sclerostin, are implicated in arterial damage and cardiovascular outcomes.
  • Understanding sclerostin's role in pediatric primary hypertension (PH) is crucial for assessing cardiovascular risk.

Purpose of the Study:

  • To evaluate serum sclerostin concentration in children and adolescents with PH.
  • To investigate the relationship between serum sclerostin and blood pressure, arterial damage, and calcium-phosphate metabolism in this population.

Main Methods:

  • Serum sclerostin levels were measured in 60 pediatric PH patients and 20 healthy controls.
  • Assessed calcium-phosphate metabolism, peripheral and central blood pressure (office and 24-h ambulatory), and arterial damage parameters.
  • Utilized multivariate analysis to identify determinants of serum sclerostin.

Main Results:

  • No significant difference in serum sclerostin was found between PH patients and controls.
  • Sclerostin correlated positively with height Z-score, phosphate, and alkaline phosphatase.
  • Sclerostin correlated negatively with age, peripheral systolic/mean blood pressure, and central systolic/mean blood pressure.
  • Multivariate analysis identified height Z-score and systolic blood pressure Z-score as significant determinants of serum sclerostin.

Conclusions:

  • Serum sclerostin levels are associated with blood pressure and height in the pediatric population.
  • These findings suggest a potential role for sclerostin in blood pressure regulation within pediatric hypertension.
  • Further research is warranted to elucidate the precise mechanisms involved.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
111
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
182
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
876
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
186
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
656